Preparation of paclitaxel-loaded cationic chitosan micelles and study of its biodistribution in mice

Mei-rong HUO,Jian-ping ZHOU,Yan WEI,Lin L(U)

DOI: https://doi.org/10.3321/j.issn:1000-5048.2006.02.008

2006-01-01

Abstract:Aim:To prepare paclitaxel-loaded cationic chitosan micelles(PTX-CCM) and to study the biodistribution of PTX-CCM and paclitaxel injection(PTX-INJ) in mice.Methods:PTX-CCM was prepared by dialysis.PTX-CCM and PTX-INJ were administered to mice through caudal veins at a dose of 20 mg/kg.The RP-HPLC method was established to determine the PTX levels in the plasma and other tissues of mice.The tissues distribution and targeting effenciency were evaluated by pharmacokinetic parameters(AUC,MRT) and targeting parameters(Re,Ce and Te).Results:The drug loading and drug encapsulation of PTX-CCM were 26.40% and 76.23%,respectively,and the diameters and Zeta potential were 164.2 nm and +23.7 mV,respectively.In comparison to PTX-INJ group,the AUCs of PTX in the liver,spleen and lung had risen 5.65,91.20 and 2.53 times respectively in PTX-CCM group.Meanwhile,the MRT were 1.83,8.40 and 1.16 times of those of control group respectively.The relative exposure(Re) and ratio of maximum concentration(Ce) for PTX-CCM in these tissues were far more than 1 and targeting efficiecy(Te) was much higher than that of control group,while PTX in the heart and kidney decreased significantly and AUC were 61.00% and 89.07% of those of control group,meanwhile,c_(max) were 52.62% and 52.94% of those of control group respectively.Conclusion:PTX-CCM shows excellent drug loading capabilities with a amount of cationic charges on their surface.It showsd a higher targeting efficiency in the liver,spleen and lung in vivo and accumulates in the tissues for relatively longer time while the levels of PTX-CCM in the heart and kidney tissues are significantly reduced which might improve the treatment efficacy of PTX and decrease the side effects.